Humoral and Cellular Responses to SARS-CoV-2 Vaccines in MS Patients on Ocrelizumab and Other Disease-modifying Therapies: A Prospective Study From NYU Multiple Sclerosis Care Center (P1-1.Virtual)Ilya Kister,Yury Patskovsky,Ryan Curtin,Iryna Voloshyna,Katherine Perdomo,Zoe Rimler,Jinglan Pei, Nicole Ferstler,Yogambigai Velmurugu,Samantha Nyovanie,Mark J. Mulligan,Joseph Kim,Ethan Tardio,Tamar Bacon,Lana Zhovtis Ryerson,Marie Samanovic-Golden,Amber Cornelius,Catarina Raposo,Jessica Priest,Ryan C. Winger,Michelle Krogsgaard,Gregg J. SilvermanNeurology（2022）引用 0|浏览1暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
